Jump to content

Mike Macaluso

From Wikipedia, the free encyclopedia

Mike Macaluso
Personal information
Born(1951-07-21)July 21, 1951
Buffalo, New York, U.S.
DiedNovember 16, 2022(2022-11-16) (aged 71)
Listed height6 ft 5 in (1.96 m)
Listed weight210 lb (95 kg)
Career information
High schoolHutchinson Central Tech
(Buffalo, New York)
CollegeCanisius (1970–1973)
NBA draft1973: 6th round, 88th overall pick
Selected by the Buffalo Braves
PositionShooting guard
Number21
Career history
1973–1974Buffalo Braves
1974–1975Israel Sabras
Stats at NBA.com Edit this at Wikidata
Stats at Basketball Reference Edit this at Wikidata

Michael Emilius Macaluso (July 21, 1951 – November 16, 2022) was an American professional basketball player. He played 30 games for the Buffalo Braves of the National Basketball Association (NBA) in the 1973–74 season.[1]

Macaluso played college basketball at Canisius College from 1970 to 1973 where he led his team in scoring in three consecutive seasons and averaged 8.7 rebounds per game, which ranks in the top-10 all-time in school history. He was inducted into the Canisius College Hall of Fame in 1989.

He was drafted by Buffalo Braves in the sixth round (88th overall) of the 1973 NBA draft. He was also drafted by the ABA's Kentucky Colonels that same year. Macaluso signed with Buffalo.

After his NBA stint, he played for the Israel Sabras in the European Professional Basketball League in 1974-75 where he helped win a championship. The league folded after that one season.

After retiring from basketball, Macaluso had a successful entrepreneurial career across various industries including multiple public life sciences enterprises. He co-founded both Ampio Pharmaceuticals, Inc. and Aytu BioPharma in 2015.

Macaluso died on November 16, 2022, at the age of 71.[2]

References

[edit]
  1. ^ "Mike Macaluso profile". basketball-reference.com. Retrieved May 21, 2014.
  2. ^ "Mike Macaluso, Canisius College basketball star who played for Braves, dies at age 71". The Buffalo News. November 29, 2022. Retrieved December 24, 2022.